Table 1 Demographic and clinical characteristics of people with vs. without Gout
|  | No Gout (N = 1,623,304) | Gout (N = 76,309) |
|---|---|---|
Age, Mean (SD) | 75.3 (7.6) | 74.9 (7.0) |
Gender, N (%) | ||
 Male | 672,755 (41.4%) | 44,740 (58.6%) |
 Female | 950,549 (58.6%) | 31,569 (41.4%) |
Race, N (%) | ||
 White | 1,403,749 (86.5%) | 63,434 (83.1%) |
 Black | 128,197 (7.9%) | 8585 (11.3%) |
 Others | 91,358 (5.6%) | 4290 (5.6%) |
Charlson-Romano comorbidity score2, Mean (SD) | 1.5 (2.5) | 2.0 (2.4) |
Charlson-Romano comorbidity score, N (%) | ||
 0 | 883,689 (54.4%) | 28,407 (37.2%) |
 1 | 163,358 (10.1%) | 10,658 (14.0%) |
  ≥ 2 | 576,257 (35.5%) | 37,246 (48.8%) |
Select Charlson-Romano comorbidities | ||
 Myocardial Infarction | 59,625 (3.7%) | 4450 (5.8%) |
 Heart Failure | 172,489 (10.6%) | 14,630 (19.2%) |
 Peripheral vascular disease | 148,616 (9.2%) | 10,082 (13.2%) |
 Cerebrovascular disease | 152,599 (9.4%) | 9046 (11.9%) |
 Dementia | 74,277 (4.6%) | 1926 (2.5%) |
 Chronic pulmonary disease | 245,086 (15.1%) | 15,297 (20.0%) |
 Connective tissue disease | 43,359 (2.7%) | 3063 (4.0%) |
 Peptic ulcer disease | 29,277 (1.8%) | 1923 (2.5%) |
 Mild liver disease | 7583 (0.5%) | 533 (0.7%) |
 Diabetes | 280,819 (17.3%) | 21,459 (28.1%) |
 Diabetes with end organ damage | 77,421 (4.8%) | 5906 (7.7%) |
 Hemiplegia | 13,144 (0.8%) | 634 (0.8%) |
Hypertension | 752,833 (46.4%) | 53,555 (70.2%) |
Hyperlipidemia | 545,421 (33.6%) | 37,898 (49.7%) |
Coronary artery disease | 267,429 (16.5%) | 21,123 (27.7%) |
Obesity | 30,761 (1.9%) | 3285 (4.3%) |